BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mancini MC, de Melo ME. The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg. Diabetol Metab Syndr 2017;9:44. [PMID: 28580018 DOI: 10.1186/s13098-017-0242-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Gasmi A, Boukhmis B, Bjørklund G, Elkhidir IH, Semenova Y, Dosa A, Piscopo S, Temitope AH, Noor S, Costea DO. Physical activity and obesity spectrum disorders in post-bariatric surgery patients: A systematic review and Meta-analysis. Crit Rev Food Sci Nutr 2022;:1-12. [PMID: 35442131 DOI: 10.1080/10408398.2022.2056868] [Reference Citation Analysis]
2 Alsafwani DM, Alotaibi HN, Alzaid JA, Alghamdi A, Almakhaita HM. Liraglutide Effect on Weight, Glycated Hemoglobin, and Blood Pressure: A Single-Center Experience in the Eastern Province of Saudi Arabia. Cureus 2022. [DOI: 10.7759/cureus.23554] [Reference Citation Analysis]
3 Dong TS, Guan M, Mayer EA, Stains J, Liu C, Vora P, Jacobs JP, Lagishetty V, Chang L, Barry RL, Gupta A. Obesity is associated with a distinct brain-gut microbiome signature that connects Prevotella and Bacteroides to the brain’s reward center. Gut Microbes 2022;14:2051999. [DOI: 10.1080/19490976.2022.2051999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Van den Eynde A, Mertens A, Vangoitsenhoven R, Meulemans A, Matthys C, Deleus E, Lannoo M, Bruffaerts R, Van der Schueren B. Psychosocial Consequences of Bariatric Surgery: Two Sides of a Coin: a Scoping Review. Obes Surg 2021;31:5409-17. [PMID: 34611828 DOI: 10.1007/s11695-021-05674-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Mehta M, Istfan NW, Apovian CM. Obesity: Overview of Weight Management. Endocr Pract 2021;27:626-35. [PMID: 33901648 DOI: 10.1016/j.eprac.2021.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Park JS, Kwon J, Choi HJ, Lee C. Clinical effectiveness of liraglutide on weight loss in South Koreans: First real-world retrospective data on Saxenda in Asia. Medicine (Baltimore) 2021;100:e23780. [PMID: 33466127 DOI: 10.1097/MD.0000000000023780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kalra S, Singal A, Lathia T. What's in a Name?Diabetes Ther. 2021;12:647-654. [PMID: 33491112 DOI: 10.1007/s13300-020-00990-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Larsen TS, Jansen KM. Impact of Obesity-Related Inflammation on Cardiac Metabolism and Function. J Lipid Atheroscler 2021;10:8-23. [PMID: 33537250 DOI: 10.12997/jla.2021.10.1.8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gupta A, Osadchiy V, Mayer EA. Brain-gut-microbiome interactions in obesity and food addiction. Nat Rev Gastroenterol Hepatol 2020;17:655-72. [PMID: 32855515 DOI: 10.1038/s41575-020-0341-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 33.0] [Reference Citation Analysis]
10 Vardanyan GS, Harutyunyan HS, Aghajanov MI, Vardanyan RS. Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects. Future Med Chem 2020;12:1865-84. [PMID: 33040605 DOI: 10.4155/fmc-2019-0361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sachinidis A, Nikolic D, Stoian AP, Papanas N, Tarar O, Rizvi AA, Rizzo M. Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors. Metabolism 2020;111:154343. [DOI: 10.1016/j.metabol.2020.154343] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
12 Wang Z, Song J, Li C, Li Y, Shen L, Dong B, Zou Z, Ma J. DNA methylation of the INSR gene as a mediator of the association between prenatal exposure to famine and adulthood waist circumference. Sci Rep 2020;10:12212. [PMID: 32699300 DOI: 10.1038/s41598-020-69120-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhao Q, Li L, Zhu Y, Hou D, Li Y, Guo X, Wang Y, Olatunji OJ, Wan P, Gong K. Kukoamine B Ameliorate Insulin Resistance, Oxidative Stress, Inflammation and Other Metabolic Abnormalities in High-Fat/High-Fructose-Fed Rats. Diabetes Metab Syndr Obes 2020;13:1843-53. [PMID: 32547146 DOI: 10.2147/DMSO.S247844] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
14 Luo S, Lenon GB, Gill H, Yuen H, Yang AWH, Hung A, Nguyen LT. Do the Natural Chemical Compounds Interact with the Same Targets of Current Pharmacotherapy for Weight Management?-A Review. Curr Drug Targets 2019;20:399-411. [PMID: 30173643 DOI: 10.2174/1389450119666180830125958] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
15 Cӑtoi AF, Vodnar DC, Corina A, Nikolic D, Citarrella R, Pérez-Martínez P, Rizzo M. Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives. Curr Pharm Des 2019;25:2038-50. [PMID: 31298152 DOI: 10.2174/1381612825666190708190437] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
16 Khalil H, Ellwood L, Lord H, Fernandez R. Pharmacological Treatment for Obesity in Adults: An Umbrella Review. Ann Pharmacother 2020;54:691-705. [PMID: 31958967 DOI: 10.1177/1060028019898912] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
17 Freitas WR Jr, Oliveira LVF, Perez EA, Ilias EJ, Lottenberg CP, Silva AS, Urbano JJ, Oliveira MC Jr, Vieira RP, Ribeiro-Alves M, Alves VLS, Kassab P, Thuler FR, Malheiros CA. Systemic Inflammation in Severe Obese Patients Undergoing Surgery for Obesity and Weight-Related Diseases. Obes Surg 2018;28:1931-42. [PMID: 29497960 DOI: 10.1007/s11695-017-3104-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
18 Rosa-Gonçalves P, Majerowicz D. Pharmacotherapy of Obesity: Limits and Perspectives. Am J Cardiovasc Drugs 2019;19:349-64. [PMID: 30793263 DOI: 10.1007/s40256-019-00328-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Selvaskandan H, Modha DE, Denton-Beaumont R, Ashton C, Hamilton RA. High-dose oral linezolid achieved rapid clinical and microbiological recovery in a severely overweight male with long-standing infected ulcers. J Antimicrob Chemother 2019;74:1755-7. [PMID: 30783670 DOI: 10.1093/jac/dkz071] [Reference Citation Analysis]
20 Sauter M, Uhl P, Majewsky M, Fresnais M, Haefeli WE, Burhenne J. An ultrasensitive UPLC–MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs. Bioanalysis 2019;11:887-98. [DOI: 10.4155/bio-2018-0322] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bellone S, Ricotti R, Solito A, Mones E, Mele C, Aimaretti G, Prodam F. Children Obesity, Glucose Tolerance, Ghrelin, and Prader Willi Syndrome. Global Perspectives on Childhood Obesity 2019. [DOI: 10.1016/b978-0-12-812840-4.00014-1] [Reference Citation Analysis]
22 Lee CJ, Kim M, An SJ. Current Treatments on Obesity. Korean J Health Promot 2019;19:171. [DOI: 10.15384/kjhp.2019.19.4.171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Neuroendocrine Regulation of Appetite and Body Weight. Clinical Neuroendocrinology 2018. [DOI: 10.1017/9781108149938.005] [Reference Citation Analysis]
24 López-Cabrera Y, Castillo-García EL, Altamirano-Espino JA, Pérez-Capistran T, Farfán-García ED, Trujillo-Ferrara JG, Soriano-Ursúa MA. Profile of three boron-containing compounds on the body weight, metabolism and inflammatory markers of diabetic rats. J Trace Elem Med Biol 2018;50:424-9. [PMID: 30262315 DOI: 10.1016/j.jtemb.2018.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
25 Pedro-Botet J, Ascaso JF, Barrios V, De la Sierra A, Escalada J, Millán J, Mostaza JM, Pérez-Martínez P, Pintó X, Salas-Salvadó J, Valdivielso P. COSMIC project: consensus on the objectives of the metabolic syndrome in clinic. Diabetes Metab Syndr Obes 2018;11:683-97. [PMID: 30464566 DOI: 10.2147/DMSO.S165740] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
26 Bishnoi M, Khare P, Brown L, Panchal SK. Transient receptor potential (TRP) channels: a metabolic TR(i)P to obesity prevention and therapy. Obes Rev 2018;19:1269-92. [PMID: 29797770 DOI: 10.1111/obr.12703] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
27 Rizzo M, Nikolic D, Patti AM, Mannina C, Montalto G, McAdams BS, Rizvi AA, Cosentino F. GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms. Biochim Biophys Acta Mol Basis Dis 2018;1864:2814-21. [PMID: 29778663 DOI: 10.1016/j.bbadis.2018.05.012] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 18.8] [Reference Citation Analysis]
28 Nikodemova M, Yee J, Carney PR, Bradfield CA, Malecki KM. Transcriptional differences between smokers and non-smokers and variance by obesity as a risk factor for human sensitivity to environmental exposures. Environ Int 2018;113:249-58. [PMID: 29459183 DOI: 10.1016/j.envint.2018.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
29 Gasbjerg LS, Gabe MBN, Hartmann B, Christensen MB, Knop FK, Holst JJ, Rosenkilde MM. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents. Peptides 2018;100:173-81. [DOI: 10.1016/j.peptides.2017.11.021] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
30 Velez-Viveros CA, González-González JG, Rodríguez-Flores M, Mancillas-Adame LG. Comparing Apples to Apples. Is it Fair to Compare Suboptimal Doses of Medications to Surgery? Obes Surg 2018;28:850-1. [PMID: 29307106 DOI: 10.1007/s11695-017-3082-y] [Reference Citation Analysis]
31 Micić D, Polovina S, Micić D. The role of anti-obesity drugs in the management of obese diabetics. Med gl Spec bol štit Zlatibor 2018;23:15-21. [DOI: 10.5937/medgla1870015m] [Reference Citation Analysis]
32 Logvinova OV, Galieva MO, Mazurina NV, Troshina EA. The place of central-acting drugs in the algorithms of treatment of primary obesity. Obes metabol 2017;14:18-23. [DOI: 10.14341/omet2017218-23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Solak M. Metabolic Syndrome – Myth or Reality in the Endocrinology Clinic. Cardiologia Croatica 2017;12:331-335. [DOI: 10.15836/ccar2017.331] [Reference Citation Analysis]